Orange Book product · Brand (NDA)
ACULAR LS
KETOROLAC TROMETHAMINE
At a glance
May 30, 2003
Approved
Brand (NDA)
Application
Not listed
TE code
2
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 30, 2003
23 yr 5 mo ago
Today
Patent 8008338 expires
Listed drug substance patent expiration.
May 24, 2027
in 11 mo
Patent 8008338*PED expires
Listed listed patent expiration.
Nov 24, 2027
in 1 yr 5 mo
Pharmaceutical detail
Active ingredient
KETOROLAC TROMETHAMINE
Strength
0.4%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
NDA 021528
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2010SPRIXBrand (NDA)
NDA 022382 · ZYLA
- 2009ACUVAILBrand (NDA)
NDA 022427 · ABBVIE
- 1997ACULAR PRESERVATIVE FREEBrand (NDA)
NDA 020811 · ALLERGAN
- 1992ACULARBrand (NDA)
NDA 019700 · ABBVIE
- 1989TORADOLBrand (NDA)
NDA 019698 · ROCHE PALO
- 2024KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 218204 · CAPLIN
- 2023KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 217166 · ASPIRO
- 2023KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 217789 · CAPLIN
- 2023KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 216759 · BIONPHARMA
- 2022KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 214456 · ALEMBIC
- 2022KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 216407 · ATNAHS PHARMA US
- 2020KETOROLAC TROMETHAMINEGeneric (ANDA)
ANDA 205190 · EUGIA PHARMA
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8008338 | May 24, 2027 | in 11 mo | SubstanceProductU-1181 |
| 8008338*PED | Nov 24, 2027 | in 1 yr 5 mo |

